• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    Amarin Corporation plc (AMRN)

    -NasdaqGM
    1.69 Up 0.15(9.74%) Mar 4, 4:00PM EST
    Add to Portfolio
    Prev Close:1.54
    Open:1.64
    Bid:1.50 x 3500
    Ask:1.76 x 200
    1y Target Est:3.55
    Beta:1.33
    Earnings Date:May 7 - May 11 (Est.)
    Day's Range:1.58 - 1.72
    52wk Range:0.78 - 2.09
    Volume:5,350,014
    Avg Vol (3m):1,837,620
    Market Cap:295.06M
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AMRN

    Comparison

    Symbol% ChgMkt Cap
    AMRNUp 9.74%295.06M
    MRKDown 0.79%164.27B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.41
    Quarterly EPS Est (Mar-15) :-0.12
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-0.06

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback